211 related articles for article (PubMed ID: 30619267)
1. Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance-Supercontrollers.
Dominguez-Molina B; Ferrando-Martinez S; Tarancon-Diez L; Hernandez-Quero J; Genebat M; Vidal F; Muñoz-Fernandez MA; Leal M; Koup R; Ruiz-Mateos E
Front Immunol; 2018; 9():2897. PubMed ID: 30619267
[TBL] [Abstract][Full Text] [Related]
2. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
3. A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.
Shen T; Chen X; Zhang W; Xi Y; Cao G; Zhi Y; Wang S; Xu C; Wei L; Lu F; Zhuang H
PLoS One; 2011; 6(8):e23550. PubMed ID: 21858166
[TBL] [Abstract][Full Text] [Related]
4. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
[TBL] [Abstract][Full Text] [Related]
5. Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection.
Barrett L; Gallant M; Howley C; Ian Bowmer M; Hirsch G; Peltekian K; Grant M
J Viral Hepat; 2011 Mar; 18(3):170-80. PubMed ID: 20497309
[TBL] [Abstract][Full Text] [Related]
6. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
[TBL] [Abstract][Full Text] [Related]
7. Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors.
Sajadi MM; Pulijala R; Redfield RR; Talwani R
AIDS; 2012 Sep; 26(15):1879-84. PubMed ID: 22824629
[TBL] [Abstract][Full Text] [Related]
8. Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
Desai SN; Dodge JL; Landay AL; Glesby MJ; Latham PS; Villacres MC; French AL; Gange SJ; Greenblatt RM; Peters MG
Medicine (Baltimore); 2016 Aug; 95(33):e4483. PubMed ID: 27537569
[TBL] [Abstract][Full Text] [Related]
9. Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort study.
Dominguez-Molina B; Tarancon-Diez L; Milanés-Guisado Y; Genebat M; Resino S; Rodriguez C; Gonzalez-García J; Rallón N; Pernas M; Casado C; Lopez-Galíndez C; León A; Benito JM; García F; Del Romero J; Viciana P; Lopez-Cortes LF; Leal M; Ruiz-Mateos E;
J Int AIDS Soc; 2020 Sep; 23(9):e25607. PubMed ID: 32909370
[TBL] [Abstract][Full Text] [Related]
10. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
Rallón N; García M; García-Samaniego J; Rodríguez N; Cabello A; Restrepo C; Álvarez B; García R; Górgolas M; Benito JM
PLoS One; 2017; 12(3):e0173943. PubMed ID: 28323897
[TBL] [Abstract][Full Text] [Related]
11. HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study.
López-Huertas MR; Palladino C; Garrido-Arquero M; Esteban-Cartelle B; Sánchez-Carrillo M; Martínez-Román P; Martín-Carbonero L; Ryan P; Domínguez-Domínguez L; Santos IL; Moral SF; Benito JM; Rallón N; Alcamí J; Resino S; Fernández-Rodríguez A; Coiras M; Briz V;
Sci Rep; 2019 Apr; 9(1):5606. PubMed ID: 30944340
[TBL] [Abstract][Full Text] [Related]
12. High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.
Ruiz-Mateos E; Ruiz-León MJ; Tarancón-Díez L; Gutiérrez C; Dronda F; Domínguez-Molina B; Pérez-Elías MJ; Moreno A; Leal M; Moreno S; Vallejo A
Virus Res; 2019 Apr; 264():40-44. PubMed ID: 30776394
[TBL] [Abstract][Full Text] [Related]
13. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
14. Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.
Rempel H; Sun B; Calosing C; Abadjian L; Monto A; Pulliam L
PLoS One; 2013; 8(2):e55776. PubMed ID: 23437063
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
[TBL] [Abstract][Full Text] [Related]
16. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.
Lauer GM; Nguyen TN; Day CL; Robbins GK; Flynn T; McGowan K; Rosenberg ES; Lucas M; Klenerman P; Chung RT; Walker BD
J Virol; 2002 Mar; 76(6):2817-26. PubMed ID: 11861849
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection.
Rodrigue-Gervais IG; Rigsby H; Jouan L; Sauvé D; Sékaly RP; Willems B; Lamarre D
J Immunol; 2010 Mar; 184(6):3134-44. PubMed ID: 20173023
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
Gonzalez VD; Landay AL; Sandberg JK
Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
[TBL] [Abstract][Full Text] [Related]
20. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease.
Santin M; Mestre M; Shaw E; Barbera MJ; Casanova A; Niubo J; Bolao F; Podzamczer D; Gudiol F
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):65-73. PubMed ID: 17938979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
